Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men

Atherosclerosis

Volumn 240, Issue 2, 2015, Pages 380-386

  Ozturk, Kadir ^a   Uygun, Ahmet ^a   Guler, Ahmet Kerem ^a   Demirci, Hakan ^a   Ozdemir, Cafer ^b   Cakir, Mehmet ^a   Sakin, Yusuf Serdar ^a   Turker, Turker ^a   Sari, Sebahattin ^a   Demirbas, Seref ^a   Karslioğlu, Yildirim ^a   Saglam, Mutlu ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arterial stiffness; Carotid intima media thickness; Flow mediated dilatation; Nonalcoholic fatty liver disease

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PULSE WAVE; RISK FACTOR; AGE; ARTERIAL STIFFNESS; ASYMPTOMATIC DISEASE; BIOPSY; CAROTID ARTERY DISEASES; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; TURKEY; VASCULAR ENDOTHELIUM; VASODILATATION; YOUNG ADULT;

ADULT; AGE FACTORS; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; BIOPSY; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; HUMANS; MALE; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TURKEY; VASCULAR STIFFNESS; VASODILATION; YOUNG ADULT;

EID: 84927130329     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.04.009     Document Type: Article

References (41)

1. Adams L.A., Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet. Med. 2005, 22:1129-1133.
2. Neuschwander-Tetri B.A. Nonalcoholic steatohepatitis and the metabolic syndrome. Am. J. Med. Sci. 2005, 330:326-335.
3. Targher G., Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007, 191:235-240.
4. Ndumele C.E., Nasir K., Conceiçao R.D., et al. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1927-1932.
5. Park B.J., Kim Y.J., Kim D.H., et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J.Gastroenterol. Hepatol. 2008, 23:900-907.
6. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N.Engl. J. Med. 2010, 363:1341-1350.
7. Maurantonio M., Ballestri S., Odoardi M.R., et al. Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk?. Arch. Med. Res. 2011, 42:337-353.
8. Yki-Järvinen H., Westerbacka J. The fatty liver and insulin resistance. Curr. Mol. Med. 2005, 5:287-295.
9. Yesilova Z., Yaman H., Oktenli C., et al. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. Am. J. Gastroenterol. 2005, 100:850-855.
10. Leach N.V., Dronca E., Vesa S.C., et al. Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. Eur. J. Intern. Med. 2014, 25:762-767.
11. Otsuka K., Fukuda S., Shimada K., et al. Serial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease. Hypertens. Res. 2014, 10.
12. Laurent S., Cockcroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 2006, 27:2588-2605.
13. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J.Am. Coll. Cardiol. 2010, 55:1318-1327.
14. Oni E.T., Agatston A.S., et al. Asystematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?. Atherosclerosis 2013, 230:258-267.
15. Fridewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
16. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37(Suppl.1):S81-S90.
17. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
18. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
19. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
20. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373-379.
21. Kim H.J., Kim H.J., Lee K.E., et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch. Intern. Med. 2004 25, 164:2169-2175.
22. Bonora E., Kiechl S., Willeit J., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003, 26:1251-1257.
23. Salvi P., Ruffini R., Agnoletti D., et al. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. J.Hypertens. 2010, 28:1699-1707.
24. Kim H.C., Kim D.J., Huh K.B. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009, 204:521-525.
25. Thakur M.L., Sharma S., Kumar A., et al. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis 2012, 223:507-511.
26. Josef P., Ali I., Ariel P., et al. Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD). Int. J. Environ. Res. Public Health 2013, 10:3409-3423.
27. Mohammadi A., Sedani H.H., Ghasemi-Rad M. Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. Vasc. Health Risk Manag. 2011, 7:661-665.
28. Dunn W., Xu R., Wingard D.L., et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am. J. Gastroenterol. 2008, 103:2263-2271.
29. Matteoni C.A., Younossi Z.M., Gramlich T. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
30. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37:1236-1241.
31. O'Leary D.H., Polak J.F., Kronmal R.A., et al. See comment in PubMed commons belowCarotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N.Engl. J. Med. 1999, 340:14-22.
32. Hodgson J.M., Woodman R.J., Croft K.D., et al. Relationships of vascular function with measures of ambulatory blood pressure variation. Atherosclerosis 2014, 233:48-54.
33. Kobayashi K., Akishita M., Yu W., et al. See comment in PubMed commons belowInterrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis 2004, 173:13-18.
34. Vlachopoulos C., Manesis E., Baou K., et al. Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: a pilot study. Am. J. Hypertens. 2010, 23:1183-1189.
35. Koivistoinen T., Virtanen M., Hutri-Kähönen N., et al. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey. Atherosclerosis 2012, 220:387-393.
36. Lunder M., Janic M., Kejzar N., Sabovic M. Associations among different functional and structural arterial wall properties and their relations to traditional cardiovascular risk factors in healthy subjects: a cross-sectional study. BMC Cardiovasc. Disord. 2012, 12:29.
37. Sunbul M., Agirbasli M., Durmus E., et al. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. Atherosclerosis 2014, 237:490-493.
38. Angulo P., Keach J.C., Batts K.P., et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30:1356-1362.
39. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37:1236-1241.
40. Chen J.Y., Chou C.H., Tsai W.C., et al. Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease. J.Am. Soc. Hypertens. 2012, 6:253-260.
41. Shiotani A., Motoyama M., Matsuda T., et al. Brachial-ankle pulse wave velocity in Japanese university students. Intern. Med. 2005, 44:696-701.